NMAD LIXTE BIOTECHNOLOGY HLDGS IN: institutional ownership and insider trading
18 funds reported holding $14.5M of LIXTE BIOTECHNOLOGY HLDGS IN in their latest 13F filings; in Q2 2026 funds net bought $9.26M, with 9 new positions and 5 funds selling out.
Largest institutional holders of NMAD
- Legacy Wealth Managment, LLC/ID — $4.46M
- VANGUARD CAPITAL MANAGEMENT LLC — $4.12M
- SCOTIA CAPITAL INC. — $2.10M
- GEODE CAPITAL MANAGEMENT, LLC — $1.06M
- BlackRock, Inc. (BLK) — $564K
- STATE STREET CORP (STT, STT-PG) — $557K
- VANGUARD FIDUCIARY TRUST CO — $499K
- VANGUARD GROUP INC — $295K
- Federation des caisses Desjardins du Quebec — $283K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $205K
5%+ owners
- Strategic EP, LLC: 5.1% (Schedule 13G, filed Jun 9, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Jul 31, 2026)